IFN-beta en es it fr

IFN-beta Brand names, IFN-beta Analogs

IFN-beta Brand Names Mixture

  • No information avaliable

IFN-beta Chemical_Formula


IFN-beta RX_link


IFN-beta fda sheet

IFN-beta msds (material safety sheet)

IFN-beta Synthesis Reference

No information avaliable

IFN-beta Molecular Weight


IFN-beta Melting Point

No information avaliable

IFN-beta H2O Solubility

No information avaliable

IFN-beta State


IFN-beta LogP


IFN-beta Dosage Forms

Solution (Subcutaneous Injection); Powder for solution

IFN-beta Indication

For treatment of relapsing/remitting multiple sclerosis

IFN-beta Pharmacology

Interferon beta upregulates the expression of MHC I proteins, allowing for increased presentation of peptides derived from viral antigens. This enhances the activation of CD8+ T cells that are the precursors for cytotoxic T lymphocytes (CTLs) and makes the macrophage a better target for CTL-mediated killing. Type I interferons also induce the synthesis of several key antiviral mediators including 2'-5' oligoadenylate synthetase (2'-5' A synthetase), beta-2 microglobulin, neopterin and protein kinase R.

IFN-beta Absorption

No information avaliable

IFN-beta side effects and Toxicity

No information avaliable

IFN-beta Patient Information


IFN-beta Organisms Affected

No information avaliable